Altogether, our findings uncover a regulatory axis whereby HIF1α negatively regulates FOXA1 protein stability in prostate cancer cells, thereby suppressing androgen receptor signaling and promoting hypoxia-responsive transcriptional programs. The gene discussed is HIF1A; the disease is prostate cancer.